As expected, SAHA sensitized the melanoma cells to T-cell killing and partially reversed SOX2-induced CD8+ T-cell tolerance, indicating that the function of SAHA might be achieved through targeting SOX2 (figure 3C, D). The gene discussed is SOX2; the disease is melanoma.